𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression

✍ Scribed by Shigeru Morishita; Seizaburo Arita

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
51 KB
Volume
18
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Introduction

Selective serotonin reuptake inhibitors (SSRIs) and dual serotonin and noradrenaline reuptake inhibitors (SNRIs) are the most commonly prescribed class of antidepressants, yet it is not known whether one is superior to another.

Aims

The purpose of this clinical practice was to compare the periods of onset of action of fluvoxamine, paroxetine and milnacipran.

Methods

A retrospective cohort analysis was carried out among out‐patients with depression treated in the Department of Psychiatry, Kawasaki Medical School Hospital, Kurashiki, Japan, in 2000 and 2001. A total of 206 patients receiving fluvoxamine, paroxetine and milnacipran were identified.

Results

The cumulative percentage of responders receiving milnacipran reached over 80% after 4 weeks, but it did reach this level for fluvoxamine or paroxetine until after 6 weeks.

Conclusions

The differential period of onset of action should help guide clinicians in determining a suitable duration of antidepressants for depression. Copyright Β© 2003 John Wiley & Sons, Ltd.

πŸ“œ SIMILAR VOLUMES

Differential effects of fluvoxamine, par
Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age
✍ Shigeru Morishita; Seizaburo Arita πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 53 KB

## Abstract ## Introduction Selective serotonin reuptake inhibitors (SSRIs) and dual serotonin and noradrenaline reuptake inhibitors (SNRIs) are the most commonly prescribed classes of antidepressants, yet it is not known whether one is superior to the other. It seems that an investigation of the

Controlled comparison of paroxetine and
Controlled comparison of paroxetine and fluvoxamine in major depression
✍ M. Ansseau; A. GabriΓ«ls; J. Loyens; F. BartholomΓ©; J. L. Evrard; A. De Nayer; R. πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 681 KB

A multicentre study compared the antidepressant efficacy and the tolerance of two selective serotonin reuptake inhibitors, paroxetine (20-30 mg/d) and fluvoxamine (50-200 mg/d) in two parallel groups of respectively 56 and 64 patients with major depression, as defined by DSM-III-R criteria. The dura

Possible predictors of response to fluvo
Possible predictors of response to fluvoxamine for depression
✍ Shigeru Morishita; Seizaburo Arita πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 49 KB

## Abstract ## Introduction An investigation of the characteristics of patients being treated with antidepressants would seem to be useful in determining which patients would be most likely benefit from antidepressant medication. ## Aims The purpose of this preliminary study was to examine the p

Onset of antidepressant activity: Reexam
Onset of antidepressant activity: Reexamining the structure of depression and multiple actions of drugs
✍ Martin M. Katz; Stephen H. Koslow; Alan Frazer πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 184 KB πŸ‘ 1 views

The question of when antidepressant drugs (AD) initiate significant clinical actions in depressed patients is still unsettled. Findings from early studies on whether there is a lag in the onset of therapeutic actions were in disagreement. More recent results with the selective serotonin reuptake inh